why choose us

First received: July 26, 2023

Clinical Trial: Allogeneic BM-MSC's in Patients With Lumbar Facet Arthropathy

Study Status: Completed

Recruit Status: RECRUITING

Condition: Facet-Mediated Low Back Pain

Study Type: INTERVENTIONAL


Official Title: Cellkine: Phase II Study Evaluating Safety and Preliminary Efficacy of Allogeneic, Culture-Expanded Bone Marrow-Derived Mesenchymal Stem Cells in Subjects With Painful Lumbar Facet Joint Arthropathies

Brief Summary: The purpose of this research study is to evaluate the safety and effect of bone marrow-derived stem cells for the treatment of low back pain.

Read more